Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kyowa Kirin Co. Ltd.

Division of Kirin Holdings Co. Ltd.

Latest From Kyowa Kirin Co. Ltd.

New Drug Launches Worldwide Dipped In 2019

The number of new active substances launched in their first market in 2019 dropped as 2018’s superlative performance gave way to something more usual.

Companies Innovation

Taisho Deal Gives BioAge First Clinical Asset

Private US venture moves into the clinic with early-stage asset from Japanese partner with potential in aging disorders.

Commercial Deals

ICER Enhanced Patient Engagement Program Will Be Led By Former Biopharma Exec

Yvette Venable has more than 20 years’ experience in patient advocacy, heath policy and biopharma communications.

Health Technology Assessment Leadership

Kyowa Kirin Goes Global With MEI’s PI3K Contender In $683m Deal

Japanese firm builds on existing alliance to gain most global rights to US company’s potential best-in-class drug for lymphoma and B-cell malignancies.

Business Strategies Commercial
See All

Company Information